CD8A and neoplasm: In addition, by operating independently of direct tumor recognition, such as by marshaling a polyclonal CD8+ T cell response, ACT with CD4+ T cells may circumvent immune escape mechanisms associated with monoclonal CD8+ T cell ACT53,54.